BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18832480)

  • 1. Role of enzymatic N-hydroxylation and reduction in flutamide metabolite-induced liver toxicity.
    Ohbuchi M; Miyata M; Nagai D; Shimada M; Yoshinari K; Yamazoe Y
    Drug Metab Dispos; 2009 Jan; 37(1):97-105. PubMed ID: 18832480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of a new N-oxidized metabolite of flutamide, N-[4-nitro-3-(trifluoromethyl)phenyl]hydroxylamine, in human liver microsomes and urine of prostate cancer patients.
    Goda R; Nagai D; Akiyama Y; Nishikawa K; Ikemoto I; Aizawa Y; Nagata K; Yamazoe Y
    Drug Metab Dispos; 2006 May; 34(5):828-35. PubMed ID: 16507648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport, metabolism, and hepatotoxicity of flutamide, drug-drug interaction with acetaminophen involving phase I and phase II metabolites.
    Kostrubsky SE; Strom SC; Ellis E; Nelson SD; Mutlib AE
    Chem Res Toxicol; 2007 Oct; 20(10):1503-12. PubMed ID: 17900172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Underlying mitochondrial dysfunction triggers flutamide-induced oxidative liver injury in a mouse model of idiosyncratic drug toxicity.
    Kashimshetty R; Desai VG; Kale VM; Lee T; Moland CL; Branham WS; New LS; Chan EC; Younis H; Boelsterli UA
    Toxicol Appl Pharmacol; 2009 Jul; 238(2):150-9. PubMed ID: 19442681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and hepatic toxicity of flutamide in cytochrome P450 1A2 knockout SV129 mice.
    Matsuzaki Y; Nagai D; Ichimura E; Goda R; Tomura A; Doi M; Nishikawa K
    J Gastroenterol; 2006 Mar; 41(3):231-9. PubMed ID: 16699857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactivation of flutamide metabolites by human liver microsomes.
    Kang P; Dalvie D; Smith E; Zhou S; Deese A; Nieman JA
    Drug Metab Dispos; 2008 Jul; 36(7):1425-37. PubMed ID: 18411402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of arylacetamide deacetylase and carboxylesterase 2 to flutamide hydrolysis in human liver.
    Kobayashi Y; Fukami T; Shimizu M; Nakajima M; Yokoi T
    Drug Metab Dispos; 2012 Jun; 40(6):1080-4. PubMed ID: 22446520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of in vitro bioactivation of flutamide and its cyano analogue: evidence for reductive activation by human NADPH:cytochrome P450 reductase.
    Wen B; Coe KJ; Rademacher P; Fitch WL; Monshouwer M; Nelson SD
    Chem Res Toxicol; 2008 Dec; 21(12):2393-406. PubMed ID: 19548358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flutamide metabolism in four different species in vitro and identification of flutamide metabolites in human patient urine by high performance liquid chromatography/tandem mass spectrometry.
    Tevell A; Lennernäs H; Jönsson M; Norlin M; Lennernäs B; Bondesson U; Hedeland M
    Drug Metab Dispos; 2006 Jun; 34(6):984-92. PubMed ID: 16540588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-progestogenic effect of flutamide on uterine expression of calbindin-D9k mRNA and protein in immature mice.
    Ji YK; Lee GS; Choi KC; Jeung EB
    Reprod Toxicol; 2006 Nov; 22(4):694-701. PubMed ID: 16777378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel glutathione conjugate of flutamide in incubations with human liver microsomes.
    Kang P; Dalvie D; Smith E; Zhou S; Deese A
    Drug Metab Dispos; 2007 Jul; 35(7):1081-8. PubMed ID: 17403914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity of the antiandrogen flutamide in isolated rat hepatocytes.
    Fau D; Eugene D; Berson A; Letteron P; Fromenty B; Fisch C; Pessayre D
    J Pharmacol Exp Ther; 1994 Jun; 269(3):954-62. PubMed ID: 8014883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of flutamide-induced hepatotoxicity in mice by Xian-Ling-Gu-Bao through induction of CYP1A2.
    Ding Y; Ma H; Xu Y; Yang F; Li Y; Shi F; Lu Y
    J Ethnopharmacol; 2021 Oct; 278():114299. PubMed ID: 34090906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the rodent Hershberger bioassay: testing of coded chemicals and supplementary molecular-biological and biochemical investigations.
    Freyberger A; Ellinger-Ziegelbauer H; Krötlinger F
    Toxicology; 2007 Sep; 239(1-2):77-88. PubMed ID: 17688994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of flutamide and 2-hydroxyflutamide and their effects on CYP1A2 mRNA in primary rat hepatocytes.
    Wang HX; Ma XC; Deng QL; Li D
    Acta Pharmacol Sin; 2002 Jun; 23(6):562-6. PubMed ID: 12060533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sex-difference on flutamide metabolism in rat liver microsomal cytochrome P450 1A2].
    Wang HX; Li D; Xu CJ; Liu X
    Yao Xue Xue Bao; 2002 Aug; 37(8):608-10. PubMed ID: 12567773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p-Aminophenol-induced hepatotoxicity in hamsters: role of glutathione.
    Fu X; Chen TS; Ray MB; Nagasawa HT; Williams WM
    J Biochem Mol Toxicol; 2004; 18(3):154-61. PubMed ID: 15252872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flutamide-induced cytotoxicity and oxidative stress in an in vitro rat hepatocyte system.
    Al Maruf A; O'Brien P
    Oxid Med Cell Longev; 2014; 2014():398285. PubMed ID: 25371773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flutamide induces ultrastructural changes in spermatids and the ectoplasmic specialization between the Sertoli cell and spermatids in mouse testes.
    Anahara R; Toyama Y; Mori C
    Reprod Toxicol; 2004 Jun; 18(4):589-96. PubMed ID: 15135853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations of the N-hydroxylation of 3'-hydroxyacetanilide, a non-hepatotoxic positional isomer of acetaminophen.
    Rashed MS; Streeter AJ; Nelson SD
    Drug Metab Dispos; 1989; 17(4):355-9. PubMed ID: 2571471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.